A proper system for meeting adverse event reporting (AER) and recordkeeping requirements under the Modernization of Cosmetics Regulations Act should comprise a database for capturing all reports and post-market surveillance that includes signal detection, triaging, and weight-of-evidence decision making, according to Rick Kingston, co-founder and president of regulatory and scientific affairs at SafetyCall International, LLC.
Speaking at the Independent Beauty Association’s FDA Cosmetics Regulation Workshop on 21 September, Kingston – whose company specializes in AE management and regulatory compliance services – identified key components of the system industry stakeholders need to develop to comply
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?